4//SEC Filing
Cross John Harry III 4
Accession 0001493152-22-009485
CIK 0001106838other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:30 PM ET
Size
5.2 KB
Accession
0001493152-22-009485
Insider Transaction Report
Form 4
Cross John Harry III
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-15+66,951→ 145,165 total
Footnotes (2)
- [F1]On December 15, 2021, the Reporting Person was granted 66,951 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.
- [F2]Includes unvested RSUs.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001806763
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:30 PM ET
- Size
- 5.2 KB